RedHill Biopharma competes with BioTime
, Compugen Ltd
, Clal Biotechnology
, and Pluristem Therapeutics
. RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late clinical-stage drugs for the treatment of gastrointestinal diseases. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 74 people.